Best Agriculture Stocks to Buy in 2020 Bayer Aktiengesellschaft (ETR:BAYN) reported first-quarter 2026 results that management said were in line with expectations, as growth in Crop Science and Consumer Health offset flat performance in Pharmaceuticals and significant... t
Carl Zeiss Meditec (ETR:AFX) reported weaker first-half results for fiscal 2025/2026 and outlined a broad restructuring plan aimed at restoring profitability over the next three years, as management pointed to currency headwinds, soft equipment demand and pressure in China’s...</
The energy firm reported Q1 EPS of $0.19 and revenue of $4.6B, exceeding analyst expectations and updating its 2026 guidance. Venture Global posted first-quarter GAAP earnings per share of $0.19, beating estimates by $0.05. Revenue surged 59.2% year-over-year to $4.6 billi
The aerospace components maker reported stronger-than-expected results driven by higher commercial aerospace demand. Ducommun posted first-quarter non-GAAP earnings per share of $0.75, exceeding estimates by $0.03, as revenue rose 9% year-over-year to $209 million. The top
The company reported Q1 non-GAAP EPS of $1.08 and revenue of $1.32B, exceeding expectations and raising annual forecasts. Qnity Electronics posted Q1 non-GAAP earnings per share of $1.08, beating estimates by $0.16, as revenue rose 17.9% year-over-year to $1.32 billion. Th
Dividend stocks have enjoyed a bit of a renaissance this year. They're also coming off three years where they deeply underperformed the S&P 500 (SNPINDEX: ^GSPC) Different stocks perform well in different environments, of course, but absolute returns aren't always t
Organigram’s Q2 revenue fell to $93.3M, missing last year’s income of $42.5M despite beating estimates by $42.82M. Organigram Global reported a Q2 net loss of $0.9 million, reversing a $42.5 million net income from the same period last year. Revenue declined 9.2% year-over
May 12 OpenAI Chief Executive Officer Sam Altman will take the witness stand on Tuesday and Wednesday, the California court said, in a clash of tech titans over Elon Musk's lawsuit against the company. The trial, in its third week, may determine the future of OpenAI and it
The healthcare analytics firm projects 2026 revenue growth supported by $30M in annual savings from Project Nexus. Health Catalyst guided to $260M-$265M in revenue for 2026, citing strong Q1 2026 performance with bookings and earnings exceeding expectations. The outlook in
several rates have moved lower compared to yesterday. According to the Zillow lender marketplace, several rates have moved lower compared to yesterday. The average 30-year fixed rate is now 6.19%, down six basis points from yesterday. The 20-year fixed rate is 6.06%
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.